Emerging Topics in Heart Failure: New Paradigms in Cardiac Amyloidosis

Emerging Topics in Heart Failure: New Paradigms in Cardiac Amyloidosis

Recent evidence suggests cardiac amyloidosis (CA) is a mostly underdiagnosed condition, particularly in the transthyretin-mediated form, and is a frequent cause of heart failure with preserved ejection fraction (HFpEF) in the elderly. New paradigms about CA also involve the development of disease-mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arquivos brasileiros de cardiologia 2020-11, Vol.115 (5), p.945-948
Hauptverfasser: Simoes, Marcus Vinicius, Martins Alves, Silvia Marinho, Fernandes, Fabio, Coelho-Filho, Otavio Rizzi, Mangini, Sandrigo
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Amyloidosis
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Heart Failure - etiology
Humans
Life Sciences & Biomedicine
Prealbumin
Science & Technology
Stroke Volume
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Recent evidence suggests cardiac amyloidosis (CA) is a mostly underdiagnosed condition, particularly in the transthyretin-mediated form, and is a frequent cause of heart failure with preserved ejection fraction (HFpEF) in the elderly. New paradigms about CA also involve the development of disease-modifying specific therapies. This article summarizes these new concepts.
ISSN:0066-782X
1678-4170
DOI:10.36660/abc.20201126